Dems' 'Better Deal' Would Create Drug Price Gouging 'Enforcer'
Plan would empower new agency to investigate and potentially fine drug manufacturers that make unjustified price increases.
You may also be interested in...
Association for Accessible Medicines says sweeping price restraints on off-patent and generic drugs are vague and will 'unleash a potentially unlimited number of enforcement actions.'
Prioritizing ANDAs entering markets with fewer than three approved generics not expected to become a major advantage until first-cycle clearances increase.
Medicare price negotiation is not a new idea – nor is the concept of using the Presidential megaphone to talk down drug prices. Will Trump and Twitter turn it into something bigger?